Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
11.05
+0.63 (6.05%)
At close: Jan 22, 2026, 4:00 PM EST
11.01
-0.04 (-0.36%)
After-hours: Jan 22, 2026, 6:29 PM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $728.97 million as of January 22, 2026. Its market cap has increased by 174.69% in one year.
Market Cap
728.97M
Enterprise Value
535.34M
1-Year Change
174.69%
Ranking
Category
Stock Price
$11.05
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $728.97M, an increase of 141.67%. That is a compound annual growth rate of 14.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 728.97M | -2.30% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 790.99M |
| Jade Biosciences | 782.99M |
| SELLAS Life Sciences Group | 767.97M |
| Nektar Therapeutics | 743.08M |
| Cullinan Therapeutics | 742.59M |
| Gyre Therapeutics | 731.67M |
| Astria Therapeutics | 718.13M |
| enGene Holdings | 712.72M |